Total Payments
$3,720
2024 Payments
$1,096
Companies
23
Transactions
211
Medicare Patients
947
Medicare Billing
$74,861
Payment Breakdown by Category
Food & Beverage$3,720 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,720 | 211 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $767.32 | 43 | $0 (2024) |
| ABBVIE INC. | $602.32 | 33 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $543.11 | 34 | $0 (2024) |
| Janssen Biotech, Inc. | $531.55 | 34 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $179.88 | 9 | $0 (2024) |
| GENZYME CORPORATION | $164.73 | 8 | $0 (2024) |
| NESTLE HEALTHCARE NUTRITION INC. | $148.47 | 2 | $0 (2023) |
| Intercept Pharmaceuticals, Inc. | $93.45 | 6 | $0 (2024) |
| Celgene Corporation | $85.13 | 5 | $0 (2024) |
| Merck Sharp & Dohme LLC | $78.45 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,096 | 61 | Takeda Pharmaceuticals U.S.A., Inc. ($233.47) |
| 2023 | $1,271 | 70 | Takeda Pharmaceuticals U.S.A., Inc. ($226.45) |
| 2022 | $1,206 | 71 | ABBVIE INC. ($302.25) |
| 2021 | $146.75 | 9 | Takeda Pharmaceuticals U.S.A., Inc. ($43.14) |
All Payment Transactions
211 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $7.36 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/16/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: LIVER DISEASE | ||||||
| 12/10/2024 | QOL Medical, LLC | SUCRAID (Drug) | Food and Beverage | Cash or cash equivalent | $13.37 | General |
| Category: THERAPY FOR CSID | ||||||
| 12/09/2024 | Takeda Pharmaceuticals U.S.A., Inc. | EOHILIA (Drug) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: INTERNAL MEDICINE | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Gastroenterology | ||||||
| 11/25/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: INTERNAL MEDICINE | ||||||
| 11/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Immunology | ||||||
| 10/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/09/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: Immunology | ||||||
| 10/07/2024 | Ipsen Biopharmaceuticals, Inc | IQIRVO (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: Rare Disease | ||||||
| 09/30/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: Gastroenterology | ||||||
| 09/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: Immunology | ||||||
| 09/23/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: LIVER DISEASE | ||||||
| 09/19/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: Immunology | ||||||
| 09/18/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: INTERNAL MEDICINE | ||||||
| 09/11/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/04/2024 | Intercept Pharmaceuticals, Inc. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 08/12/2024 | Lilly USA, LLC | OMVOH (Drug) | Food and Beverage | In-kind items and services | $18.51 | General |
| Category: Immunology | ||||||
| 08/07/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: Immunology | ||||||
| 08/07/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.70 | General |
| Category: Gastroenterology | ||||||
| 08/05/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $19.34 | General |
| Category: GI | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 584 | 658 | $213,140 | $44,956 |
| 2022 | 5 | 342 | 365 | $103,117 | $27,660 |
| 2021 | 1 | 21 | 21 | $9,009 | $2,245 |
Total Patients
947
Total Services
1,044
Medicare Billing
$74,861
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 306 | 350 | $121,100 | $25,010 | 20.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 96 | 96 | $42,144 | $9,052 | 21.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 142 | 155 | $36,580 | $8,214 | 22.5% |
| 91065 | Measurement of hydrogen in breath to test for stomach and bowel symptoms | Office | 2023 | 17 | 34 | $8,738 | $1,668 | 19.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $3,456 | $831.96 | 24.1% |
| 91200 | Measurement of liver stiffness | Office | 2023 | 11 | 11 | $1,122 | $179.61 | 16.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 165 | 177 | $49,560 | $14,238 | 28.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 72 | 72 | $30,888 | $7,195 | 23.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 81 | 81 | $15,390 | $4,485 | 29.1% |
| 91065 | Measurement of hydrogen in breath to test for stomach and bowel symptoms | Office | 2022 | 12 | 23 | $5,911 | $1,317 | 22.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 12 | 12 | $1,368 | $424.44 | 31.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 21 | 21 | $9,009 | $2,245 | 24.9% |
About Samantha Nice, APRN
Samantha Nice, APRN is a Family healthcare provider based in Lincoln, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/08/2021. The National Provider Identifier (NPI) number assigned to this provider is 1497424071.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Samantha Nice, APRN has received a total of $3,720 in payments from pharmaceutical and medical device companies, with $1,096 received in 2024. These payments were reported across 211 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($3,720).
As a Medicare-enrolled provider, Nice has provided services to 947 Medicare beneficiaries, totaling 1,044 services with total Medicare billing of $74,861. Data is available for 3 years (2021–2023), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Lincoln, NE
- Active Since 09/08/2021
- Last Updated 11/29/2023
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1497424071
Products in Payments
- ENTYVIO (Biological) $655.33
- XIFAXAN (Drug) $526.27
- STELARA (Biological) $464.31
- DUPIXENT (Biological) $344.61
- RINVOQ (Biological) $209.46
- SKYRIZI (Biological) $173.24
- ZENPEP (Drug) $148.47
- OCALIVA (Drug) $93.45
- EOHILIA (Drug) $84.01
- DIFICID (Drug) $78.45
- Linzess (Drug) $68.28
- ZEPOSIA (Drug) $68.01
- TREMFYA (Drug) $67.24
- HUMIRA (Biological) $66.90
- VOQUEZNA (Drug) $52.11
- LINZESS (Drug) $50.16
- IBSRELA (Drug) $49.03
- CREON (Drug) $47.19
- RESMETIROM (Drug) $42.92
- MAVYRET (Drug) $42.25
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Lincoln
Mr. Shrenik Vyas, Fnp-C, FNP-C
Family — Payments: $7,719
Family $7,719
Mrs. Mary Glade, Aprn, APRN
Family — Payments: $5,203
Family $5,203
Jennifer Harrison
Family — Payments: $4,853
Family $4,853
Alyson Ferguson, Aprn-Fnp-C, APRN-FNP-C
Family — Payments: $4,725
Family $4,725
Lori Mallory, Aprn, APRN
Family — Payments: $3,974
Family $3,974
Connie Duda, Cfnp, CFNP
Family — Payments: $3,896
Family $3,896